Contraception in the COVID-19 pandemic: recommendations from the Korean society of contraception and reproductive healthopen access
- Authors
- Lee, J.H.; Song, J.Y.; Yi, K.W.; Kim, J.J.; Hwang, K.R.; Shin, J.-H.; Lee, J.Y.; Chae, H.D.
- Issue Date
- 2022
- Publisher
- Korean Society of Obstetrics and Gynecology
- Keywords
- Combined; Contraception; Contraceptives; Covid-19; Covid-19 vaccines; Long-acting reversible contraception; Oral
- Citation
- Obstetrics and Gynecology Science, v.65, no.2, pp.125 - 132
- Indexed
- SCOPUS
KCI
- Journal Title
- Obstetrics and Gynecology Science
- Volume
- 65
- Number
- 2
- Start Page
- 125
- End Page
- 132
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/145991
- DOI
- 10.5468/ogs.21322
- ISSN
- 2287-8572
- Abstract
- Coronavirus disease 2019 (COVID-19) is associated with a systemic inflammatory response that activates coagulation in symptomatic patients. In addition, a rare form of thrombosis has been reported in people who received the COVID-19 vaccine, most of whom were women younger than 50 years of age. Considering that hormonal contraceptive methods widely used by women of childbearing age increase the risk of thrombosis, the development of guidelines for the use of hormonal contraceptives in the era of the COVID-19 pandemic is necessary. In this context, the Korean Society of Contraception and Reproductive Health provides guidelines for issues regarding contraception and reproductive health during the pandemic © 2022 Korean Society of Obstetrics and Gynecology
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medical Science > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.